Decreased tissue distribution of L-carnitine in juvenile visceral steatosis mice
- PMID: 10087008
Decreased tissue distribution of L-carnitine in juvenile visceral steatosis mice
Abstract
We kinetically analyzed the disposition of L-carnitine of juvenile visceral steatosis (JVS) mice compared with that of normal mice to elucidate the mechanism of the systemic L-carnitine deficiency of JVS mice. There were significant differences in the plasma concentration-time course of total radioactive carnitine (L-[3H]carnitine, [acetyl-3H]carnitine, and other [acyl-3H]carnitines) between normal and JVS mice after a single i.v. or p.o. administration of L-[3H]carnitine (250 ng/kg). The oral bioavailability of L-[3H]carnitine in JVS mice (0.341) was about half of that in normal mice (0.675). The cumulative urinary excretion of total radioactive carnitine in JVS mice was about 10-fold more than that in normal mice, and the total clearance of unchanged L-[3H]carnitine for JVS mice (6.70 ml/min) was significantly higher than that for normal mice (2.45 ml/min). The distribution volume at the steady state of unchanged L-[3H]carnitine in JVS mice (1.10 liters/kg) was significantly smaller than that in normal mice (8.16 liters/kg). At 4 h after an i.v. administration, the apparent tissue-to-plasma concentration ratios of unchanged L-[3H]carnitine for various tissues of JVS mice, except for brain, were about one half to one 20th of those in normal mice. In conclusion, this in vivo disposition kinetic study of L-carnitine supports the previous in vitro finding that the L-carnitine transporter is absent or functionally deficient in JVS mice because the renal reabsorption, the intestinal absorption, and the apparent tissue-to-plasma concentration ratios in JVS mice are significantly lower than those in normal mice. The JVS mouse should be a useful experimental model for studying carnitine deficiency diseases.
Similar articles
-
Genetic deficiency of carnitine/organic cation transporter 2 (slc22a5) is associated with altered tissue distribution of its substrate pyrilamine in mice.Biopharm Drug Dispos. 2009 Dec;30(9):495-507. doi: 10.1002/bdd.681. Biopharm Drug Dispos. 2009. PMID: 19821448
-
Toxicity of valproic acid in mice with decreased plasma and tissue carnitine stores.J Pharmacol Exp Ther. 2008 Feb;324(2):568-75. doi: 10.1124/jpet.107.131185. Epub 2007 Nov 6. J Pharmacol Exp Ther. 2008. PMID: 17986647
-
Effect of carnitine deprivation on carnitine homeostasis and energy metabolism in mice with systemic carnitine deficiency.Ann Nutr Metab. 2008;52(2):136-44. doi: 10.1159/000127390. Epub 2008 Apr 15. Ann Nutr Metab. 2008. PMID: 18417958
-
Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism.Ann N Y Acad Sci. 2004 Nov;1033:30-41. doi: 10.1196/annals.1320.003. Ann N Y Acad Sci. 2004. PMID: 15591001 Review.
-
Antagonizing effect of AP-1 on glucocorticoid induction of urea cycle enzymes: a study of hyperammonemia in carnitine-deficient, juvenile visceral steatosis mice.Mol Genet Metab. 2000 Dec;71(4):545-51. doi: 10.1006/mgme.2000.3093. Mol Genet Metab. 2000. PMID: 11136545 Review.
Cited by
-
Absorbing competition for carnitine.J Physiol. 2001 Apr 15;532(Pt 2):283. doi: 10.1111/j.1469-7793.2001.0283f.x. J Physiol. 2001. PMID: 11306647 Free PMC article. No abstract available.
-
Organic Cation Transporters in Human Physiology, Pharmacology, and Toxicology.Int J Mol Sci. 2020 Oct 24;21(21):7890. doi: 10.3390/ijms21217890. Int J Mol Sci. 2020. PMID: 33114309 Free PMC article. Review.
-
Regulation of Genes Involved in Carnitine Homeostasis by PPARα across Different Species (Rat, Mouse, Pig, Cattle, Chicken, and Human).PPAR Res. 2012;2012:868317. doi: 10.1155/2012/868317. Epub 2012 Oct 23. PPAR Res. 2012. PMID: 23150726 Free PMC article.
-
Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB(0,+).Am J Physiol Gastrointest Liver Physiol. 2007 Nov;293(5):G1046-53. doi: 10.1152/ajpgi.00233.2007. Epub 2007 Sep 13. Am J Physiol Gastrointest Liver Physiol. 2007. PMID: 17855766 Free PMC article.
-
The Role of the Carnitine/Organic Cation Transporter Novel 2 in the Clinical Outcome of Patients With Locally Advanced Esophageal Carcinoma Treated With Oxaliplatin.Front Pharmacol. 2021 Sep 16;12:684545. doi: 10.3389/fphar.2021.684545. eCollection 2021. Front Pharmacol. 2021. PMID: 34603016 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases